Velano Vascular reels in $25M to keep building blood-draw business
The San Francisco-based company hopes its PIVO device, which uses an existing catheter already inserted in patients to draw blood, becomes the standard in hospitals nationwide.
The San Francisco-based company hopes its PIVO device, which uses an existing catheter already inserted in patients to draw blood, becomes the standard in hospitals nationwide.
Cleveland-based University Hospitals Case Medical Center announced today its collaboration with Velano, making it the first major U.S. academic medical center to commercially adopt the company’s PIVO innovation.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.